Abstract
Manic depressive illness is a poorly understood condition whose causes are primary (possibly hereditary) as well as secondary. It is difficult to diagnose and treat and at the present time, lithium and anticonvulsants remain the preferred medications for the acute phase of mania. However, concomitant use of benzodiazepines or neuroleptics may be helpful to facilitate early response to treatment. Management of lithium refractory patients unresponsive to reasonable trials of anticonvulsants may make it necessary for the psychiatrist to use electroconvulsive therapy, generally considered a safe and effective alternative. Evaluation of concurrent illnesses and recognition of side effects in these treatments are also important to optimize results.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
